Integer (ITGR - Free Report) closed at $77.10 in the latest trading session, marking a +0.19% move from the prior day. This move lagged the S&P 500's daily gain of 0.66%. Meanwhile, the Dow gained 1.03%, and the Nasdaq, a tech-heavy index, added 0.46%.
Coming into today, shares of the medical device outsource manufacturer had lost 10.14% in the past month. In that same time, the Medical sector lost 0.8%, while the S&P 500 gained 3.97%.
Wall Street will be looking for positivity from ITGR as it approaches its next earnings report date. This is expected to be May 2, 2019. In that report, analysts expect ITGR to post earnings of $0.80 per share. This would mark year-over-year growth of 31.15%. Meanwhile, our latest consensus estimate is calling for revenue of $304.10 million, down 20.34% from the prior-year quarter.
ITGR's full-year Zacks Consensus Estimates are calling for earnings of $4.21 per share and revenue of $1.27 billion. These results would represent year-over-year changes of +10.79% and -2.38%, respectively.
It is also important to note the recent changes to analyst estimates for ITGR. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. ITGR is currently a Zacks Rank #2 (Buy).
Looking at its valuation, ITGR is holding a Forward P/E ratio of 18.3. Its industry sports an average Forward P/E of 33.45, so we one might conclude that ITGR is trading at a discount comparatively.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 101, which puts it in the top 40% of all 250+ industries.
The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow ITGR in the coming trading sessions, be sure to utilize Zacks.com.